Cargando…
Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
The effect of Nicotinamide and/or treatment with Fluosol DA and Carbogen breathing on the radiation response of 500-750 mg SCCVII and KHT tumours has been evaluated. Pretreatment with Fluosol DA/Carbogen or Nicotinamide resulted in relatively modest enhancements of radiation damage with enhancement...
Autores principales: | Chaplin, D. J., Horsman, M. R., Aoki, D. S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971634/ https://www.ncbi.nlm.nih.gov/pubmed/1846549 |
Ejemplares similares
-
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
por: Chaplin, D. J., et al.
Publicado: (1993) -
Perfluorocarbon nanodroplets can reoxygenate hypoxic tumors in vivo without carbogen breathing
por: Xiang, Yun, et al.
Publicado: (2019) -
Effects of intravenously infused Fluosol-DA 20% in rats()
por: West, Laurie, et al.
Publicado: (1986) -
Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.
por: Hoskin, P. J., et al.
Publicado: (1997) -
Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.
por: Rojas, A., et al.
Publicado: (1993)